DANIEL LYNCH Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL LYNCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of DANIEL LYNCH for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 49.09 | 3,125 | 153,406 | 219,342 | 222.5 K to 219.3 K (-1.40 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 50.12 | 21,474 | 1,076,277 | 222,467 | 243.9 K to 222.5 K (-8.80 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 51.17 | 7,901 | 404,294 | 243,941 | 251.8 K to 243.9 K (-3.14 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 5.50 | 1,992 | 10,957 | 23,842 | |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,008 | 4,189 | 0 | |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 110.48 | 800 | 88,385 | 2,800 | 3.6 K to 2.8 K (-22.22 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 109.74 | 1,000 | 109,740 | 3,600 | 4.6 K to 3.6 K (-21.74 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 108.29 | 2,200 | 238,237 | 4,600 | 6.8 K to 4.6 K (-32.35 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 5.50 | 1,992 | 10,957 | 6,800 | 4.8 K to 6.8 K (+41.43 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,008 | 4,189 | 4,808 | 2.8 K to 4.8 K (+71.71 %) |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,500 | 5,216 | 2,008 | |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 120.03 | 2,500 | 300,070 | 2,800 | 5.3 K to 2.8 K (-47.17 %) |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,500 | 5,216 | 5,300 | 2.8 K to 5.3 K (+89.29 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,500 | 5,216 | 4,508 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 111.00 | 5,600 | 621,600 | 5,600 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 110.20 | 2,500 | 275,488 | 2,800 | 5.3 K to 2.8 K (-47.17 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,500 | 5,216 | 5,300 | 2.8 K to 5.3 K (+89.29 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Grant | A | 0.00 | 1,400 | 0 | 2,800 | 1.4 K to 2.8 K (+100.00 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,263 | 4,722 | 7,008 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 100.14 | 2,263 | 226,622 | 1,400 | 3.7 K to 1.4 K (-61.78 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,263 | 4,722 | 3,663 | 1.4 K to 3.7 K (+161.64 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 1,000 | 2,086 | 9,271 | |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 90.00 | 1,000 | 90,002 | 1,400 | 2.4 K to 1.4 K (-41.67 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 1,000 | 2,086 | 2,400 | 1.4 K to 2.4 K (+71.43 %) |